Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rémi Gagnon

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Allergy and Clinical Immunology|June 6, 2003
Selective celecoxib-associated anaphylactoid reactionRémi Gagnon, Marlène Julien, Phil Gold
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 8, 2019
Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?Anne K Ellis, Rémi Gagnon, Eva Hammerby, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 16, 2024
Allergen immunotherapyJean-Nicolas Boursiquot, Rémi Gagnon, Jaclyn Quirt, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 25, 2002
Recurrent acute epiglottitis in adults: defective antibody responseRémi Gagnon, Pierre-Michel Bédard, Louise Côté, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 9, 2021
Sublingual immunotherapy tablet: a cost-minimizing alternative in the treatment of tree pollen-induced seasonal allergic rhinitis in CanadaAnne K Ellis, Rémi Gagnon, Eva Hammerby, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 18, 2023
Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitisAnne K Ellis, Douglas P Mack, Rémi Gagnon, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 22, 2023
Tolerability of sublingual versus vestibular allergy immunotherapy tablet administration: A randomized pilot studyMarie-Lee Simard, Natalija Novak, Jean-Philippe Drolet, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 5, 2016
Clinical Approach Used in Medical Consultations for Allergic-Like Events Following Immunization: Case Series Report in Relation to Practice GuidelinesJoseline G Zafack, Gaston De Serres, Isabelle Rouleau, et al.
International Journal of Emergency Medicine|March 30, 2022
Bradykinin-induced angioedema in the emergency departmentJacques Hébert, Jean-Nicolas Boursiquot, Hugo Chapdelaine, et al.
Pediatric Pulmonology|July 29, 2025
Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improves Outcomes Compared With Placebo Plus Continued High-Dose ICS in Children With Uncontrolled Moderate-to-Severe Type 2 AsthmaLeonard B Bacharier, Jorge F Maspero, Nikolaos G Papadopoulos, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Allergy and Clinical Immunology|June 6, 2003
Selective celecoxib-associated anaphylactoid reactionRémi Gagnon, Marlène Julien, Phil Gold
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 8, 2019
Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?Anne K Ellis, Rémi Gagnon, Eva Hammerby, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 16, 2024
Allergen immunotherapyJean-Nicolas Boursiquot, Rémi Gagnon, Jaclyn Quirt, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 25, 2002
Recurrent acute epiglottitis in adults: defective antibody responseRémi Gagnon, Pierre-Michel Bédard, Louise Côté, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 9, 2021
Sublingual immunotherapy tablet: a cost-minimizing alternative in the treatment of tree pollen-induced seasonal allergic rhinitis in CanadaAnne K Ellis, Rémi Gagnon, Eva Hammerby, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 18, 2023
Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitisAnne K Ellis, Douglas P Mack, Rémi Gagnon, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 22, 2023
Tolerability of sublingual versus vestibular allergy immunotherapy tablet administration: A randomized pilot studyMarie-Lee Simard, Natalija Novak, Jean-Philippe Drolet, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 5, 2016
Clinical Approach Used in Medical Consultations for Allergic-Like Events Following Immunization: Case Series Report in Relation to Practice GuidelinesJoseline G Zafack, Gaston De Serres, Isabelle Rouleau, et al.
International Journal of Emergency Medicine|March 30, 2022
Bradykinin-induced angioedema in the emergency departmentJacques Hébert, Jean-Nicolas Boursiquot, Hugo Chapdelaine, et al.
Pediatric Pulmonology|July 29, 2025
Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improves Outcomes Compared With Placebo Plus Continued High-Dose ICS in Children With Uncontrolled Moderate-to-Severe Type 2 AsthmaLeonard B Bacharier, Jorge F Maspero, Nikolaos G Papadopoulos, et al.
Pageof 3